{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:33:03Z","timestamp":1789162383967,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1245\/s10434-009-0470-0","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T18:26:27Z","timestamp":1241461587000},"page":"2014-2017","source":"Crossref","is-referenced-by-count":23,"title":["Importance of Early Splenectomy in Patients with Hepatosplenic T-Cell Lymphoma and Severe Thrombocytopenia"],"prefix":"10.1245","volume":"16","author":[{"given":"Andrew A.","family":"Gumbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen A.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,1]]},"reference":[{"issue":"6","key":"470_CR1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.cco.0000245309.74767.20","volume":"18","author":"OA O\u2019Connor","year":"2006","unstructured":"O\u2019Connor OA. Pralatrexate: an emerging new agent with activity in T-cell lymphomas Curr Opin Oncol. 2006;18(6):591\u20137.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"470_CR2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","volume":"14","author":"E Weidmann","year":"2000","unstructured":"Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990 Leukemia. 2000;14(6):991\u20137.","journal-title":"Leukemia"},{"issue":"2","key":"470_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10428190500293321","volume":"47","author":"ML Moleti","year":"2006","unstructured":"Moleti ML, Testi AM, Giona F, et al. Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone Leuk Lymphoma. 2006;47(2):333\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"470_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s002770050272","volume":"74","author":"S Sallah","year":"1997","unstructured":"Sallah S, Smith SV, Lony LC, Woodard P, Schmitz JL, Folds JD. Gamma\/delta T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia Ann Hematol. 1997;74(3):139\u201342.","journal-title":"Ann Hematol"},{"issue":"12","key":"470_CR5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1517\/14712598.7.12.1869","volume":"7","author":"G Veres","year":"2007","unstructured":"Veres G, Baldassano RN, Mamula P. Infliximab therapy for pediatric Crohn\u2019s disease Expert Opin Biol Ther. Dec 2007;7(12):1869\u201380.","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"470_CR6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2165\/00003495-200767120-00005","volume":"67","author":"G Veres","year":"2007","unstructured":"Veres G, Baldassano RN, Mamula P. Infliximab therapy in children and adolescents with inflammatory bowel disease Drugs. 2007;67(12):1703\u201323.","journal-title":"Drugs"},{"issue":"4","key":"470_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/j.seminhematol.2006.07.002","volume":"43","author":"OA O\u2019Connor","year":"2006","unstructured":"O\u2019Connor OA, Hamlin P. New drugs for the treatment of advanced-stage diffuse large cell lymphomas Semin Hematol. Oct 2006;43(4):251\u201361.","journal-title":"Semin Hematol"},{"issue":"3","key":"470_CR8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.2007.06658.x","volume":"139","author":"OA O\u2019Connor","year":"2007","unstructured":"O\u2019Connor OA, Hamlin PA, Portlock C, et al. Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma Br J Haematol. 2007;139(3):425\u20138.","journal-title":"Br J Haematol"},{"issue":"8","key":"470_CR9","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/ibd.20169","volume":"13","author":"JR Rosh","year":"2007","unstructured":"Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn\u2019s disease: a cautionary tale? Inflamm Bowel Dis. Aug 2007;13(8):1024\u201330.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"470_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","volume":"44","author":"AC Mackey","year":"2007","unstructured":"Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease J Pediatr Gastroenterol Nutr. Feb 2007;44(2):265\u20137.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"470_CR11","first-page":"193","volume":"30","author":"PG Isaacson","year":"1997","unstructured":"Isaacson PG. Primary splenic lymphoma Cancer Surv. 1997;30:193\u2013212.","journal-title":"Cancer Surv"},{"issue":"8","key":"470_CR12","first-page":"593","volume":"104","author":"JH Chen","year":"2005","unstructured":"Chen JH, Chan DC, Lee HS, et al. Spontaneous splenic rupture associated with hepatosplenic gammadelta T-cell lymphoma J Formos Med Assoc. 2005;104(8):593\u20136.","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"470_CR13","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","volume":"175","author":"JP Farcet","year":"1990","unstructured":"Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta Blood. Jun 1 1990;75(11):2213\u20139.","journal-title":"Blood"},{"key":"470_CR14","doi-asserted-by":"crossref","unstructured":"Gumbs AA, Bouhanna P, Bar-Zakai B, Briennon X, Gayet B. Laparoscopic partial splenectomy using radiofrequency ablation. J Laparoendosc Adv Surg Tech. 2008;18(4):611\u20133.","DOI":"10.1089\/lap.2007.0194"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0470-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0470-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0470-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T22:26:27Z","timestamp":1589754387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0470-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0470-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,1]]}}}